Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06137274

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-04-01

35

Participants Needed

1

Research Sites

176 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the study is to determine if it is feasible to use magnetic resonance imaging (MRI) to adjust a portion of radiation therapy for patients with head and neck squamous cell carcinoma . The technique under study will be used to personalize the study treatment based on response, keeping all treatments within standard of care guidelines.

CONDITIONS

Official Title

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form provided
  • Willingness to comply with all study procedures and availability for the study duration
  • ECOG performance status of 0 or 1
  • Histologically or cytologically confirmed squamous cell carcinoma of oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or unknown primary in the neck
  • Measurable disease at primary site or neck per RECIST 1.1
  • Adequate hematologic, hepatic, and renal function if planned to receive chemotherapy
  • INR and prothrombin time within normal limits within 28 days before randomization; stable anticoagulation allowed
  • Negative serum pregnancy test before starting study treatment in women of childbearing potential
Not Eligible

You will not qualify if you...

  • Pregnancy or lactation
  • Prior radiotherapy to the head and neck or prior systemic therapy for the index cancer
  • Prior definitive surgery for the index cancer
  • Presence of distant metastatic disease
  • Uncontrolled intercurrent illness including ongoing infection or psychiatric/social conditions limiting compliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Moffitt Cancer Center

Tampa, Florida, United States, 33612

Actively Recruiting

Loading map...

Research Team

A

Ashley Brennaman

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC | DecenTrialz